Michael Lee，VP of Engineering & Technology, I-MAB Bio Company

Topic: Outlook on AI MFG Facility of Biologics

  Speaker Bio

Current: VP of Engineering & Technology, I-MAB Bio Company

Experience:

1. Sr. VP of Mab-Venture Bio, Shanghai;

3. Director of GZ New Facility Project, BeiGene Bio;

4. Plant Director, JHL Bio;

5. Sr. VP, Shanghai Biomabs;

6. Director of Bio MFG Facility Projects, Merial;

7. VP of Shanghai Roche;

8. Technical Director of ScinoPharm;

9. Plant Director of Boehringer Ingelheim;

10. Plant Director of GSK.

 Presentation Summary

1. The Bio-MFG industry needs to have facility & integrated, streamlined systems that assure quality & compliance, reduce resource and operational costs & for effective SCM.

2. To tackle the challenges today and maintain a leadership position tomorrow, the Bio FoF is to be prepared for current today & flexible for new tomorrow on operational excellence.

3. The explosion of data is to be managed into digital transformation.

4. Facility & Systems are to facilitate continuous improvements in manufacturing, compliance/audits, risk management, validation, new facility startup, and company knowledge management.